Technology

Synthetic “switch” is a pivotal step for smart insulin therapy

3 August 2021 | By Anna Begley (Drug Target Review)

A novel synthetic “switch” has been developed that could hold the key to revolutionary smart insulin therapy for diabetic patients.

Thalamus revealed as key area to target for certain brain disorders

2 August 2021 | By Anna Begley (Drug Target Review)

Research shows that cells gather more data inside the thalamus than once believed, potentially changing medicines for brain disorders.

Novel insulin-producing implant to be created for type 1 diabetics

30 July 2021 | By Anna Begley (Drug Target Review)

JDRF funds development of an insulin-producing implant to regulate blood glucose levels in type 1 diabetes patients.

ebook: High-Throughput Data Management in process development

21 July 2021 | By IDBS

Cell Line Development and cell culture process teams, are you geared up to leverage the vast amount of data generated by high-throughput?

New microscopy method could lead to advancements in cell biology

7 July 2021 | By Anna Begley (Drug Target Review)

Researchers at UT Southwestern have invented a novel microscopy method that could open new avenues of advanced microscopy.

Whitepaper: Buying a digital informatics system for your R&D?

2 July 2021 | By IDBS

Examining existing R&D processes with a consolidated approach enables the stop of disjointed workflows to engage on the digitisation journey.

Application note: Pushing the boundaries in pharmaceutical hit discovery with the novel waveRAPID^® kinetic assay

22 June 2021 | By Creoptix

We demonstrate the power of waveRAPID in streamlining the kinetic characterisation of large numbers of drug hit compounds, with results comparable to traditional surface plasmon resonance (SPR) and high reproducibility.

Application note: Improving and simplifying the design of knock-in experiments using the TrueDesign Genome Editor

21 June 2021 | By Thermo Fisher Scientific

Genome editing technologies have given investigators the power to unlock a variety of new applications and experimental approaches. While gene knockouts have been achievable for several years, successful gene knock-ins have remained elusive due to the low efficiency of homology-directed repair (HDR).

Under the microscope: Exploring phage display technologies for drug discovery and early development

21 June 2021 | By IRBM Science park

With over 20 years’ of expertise in phage display, IRBM applies its extensive peptide and antibody libraries to discover lead therapeutic candidates. Dr Licia Tomei, Director of Display Technologies, IRBM, discusses the company’s phage display capabilities and how they accelerate the drug discovery process.

Realise the true power of your online, atline and offline biologics data

22 April 2021 | By IDBS

Register today for our on-demand upcoming webinar and discover more on about Polar High-Throughput Process Development (HTPD).

Product hub: The world’s first BioPharma Lifecycle Management system – navigating your biopharma lifecycle

30 March 2021 | By IDBS Polar

Here, we present IDBS Polar, a platform that securely manages drug progression in contexts of workflow, integration and insight.

The discovery and challenges of antibodies targeting GPCRs

26 February 2021 | By Domain Therapeutics

Watch our on-demand webinar which focused on the progress achieved in G protein-coupled receptor (GPCR) therapeutic antibody-based discovery and development.

Sino Biological Inc.

LEAP proton therapy could target cancer cells that resist treatment

18 February 2021 | By Victoria Rees (Drug Target Review)

A proton therapy that targets cancer cells which are resistant to treatment has shown success, sparing surrounding healthy cells.

TALEN is a more efficient gene editing tool for tightly packed DNA, finds study

28 January 2021 | By Hannah Balfour (Drug Target Review)

TALEN was shown to be almost five times more efficient than CRISPR-Cas9 at locating and editing genes in heterochromatin.